Point72 Hong Kong LTD Arcutis Biotherapeutics, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $9,912 - $13,475	607 Added 102.88%	1,197 $26,000
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $8,484 - $13,446	590 New	590 $11,000
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $11,490 - $16,151	-596 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $14,554 - $20,711	596 New	596 $16,000
Q1 2021 May 17, 2021	SELL	$24.47 - $36.98 $4,306 - $6,508	-176 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $3,136 - $5,584	176 New	176 $5,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.